World

FDA authorizes remdesivir as emergency treatment for COVID-19

Posted

The U.S. Food and Drug Administration has granted authorization to Gilead Sciences Inc for emergency use of its experimental antiviral drug remdesivir to treat patients with COVID-19, the agency and President Donald Trump said on Friday. This report produced by Jillian Kitchener.